Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
Radheshyam Meher, Senior Resident at AIIMS, reposted from International Society of Blood Transfusion (ISBT) on LinkedIn, adding:
“Honoured to be featured as a contributor to the Transfusion Evidence Round-Up– International Childhood Cancer Day 2026, an initiative by the International Society of Blood Transfusion (ISBT) and the Transfusion Evidence Library (TEL), in collaboration with the ISBT Cellular Therapies Working Party.
This special edition highlights key advances at the intersection of Transfusion Medicine, Paediatric Haematology and Cellular Therapies. Being part of an international editorial team committed to translating evidence into clinical practice has been both a privilege and a learning experience.
Grateful to my colleagues and mentors across the global transfusion and cell therapy community for their collaboration and dedication to advancing patient care. I look forward to continued contributions that bridge science, clinical practice, and education.
Thanks to International Society of Blood Transfusion (ISBT) and Allison Mo for providing me this wonderful opportunity.”
Quoting International Society of Blood Transfusion (ISBT)‘s post:
“Last Sunday marked International Childhood Cancer Day, and to recognise the occasion, we’ve teamed up with the ISBT Cellular Therapies Working Group to share a special joint Round-Up highlighting the latest developments in Transfusion Medicine and Cell Therapy.
In this edition, we take a closer look at research shaping paediatric haematology and stem cell transplantation, including insights from the FORUM Trial on how minimal residual disease influences outcomes in childhood acute lymphoblastic leukaemia. We also explore progress in TCRαβ/CD19-depleted haematopoietic stem cell transplantation, second transplant strategies for relapsed acute myeloid leukaemia, and outcomes following CAR-T therapy in children and young people.
Whether you work in transfusion, cell therapy research, or have an interest in paediatric oncology, this curated top-ten selection brings together valuable insights from across both fields.”
Stay updated with Hemostasis Today.
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden